China SXT Pharmaceuticals, Inc. (SXTC) Form 6-K — Jul 24, 2026
China SXT Pharmaceuticals, Inc. closed a registered direct offering of 4,500,000 units at a purchase price of $2.00 per unit, generating aggregate gross proceeds of $9,000,000. Each Unit consists of one Class A ordinary share and one warrant, with the warrant carrying an initial exercise price of $3.20 per share and a term of one year. The warrants include a notable "zero price exercise" provision, allowing holders to receive shares without cash payment under certain conditions, potentially leading to the issuance of up to 63,000,000 Class A Ordinary Shares.
Key figures
- Gross Proceeds
- 9000000
- Offering Price
- 2
- Shares Offered
- 4500000
- Warrant Term Years
- 1
- Warrant Exercise Price
- 3.2
- Zero Exercise Shares Cap
- 63000000
- Placement Agent Fee Percent
- 7
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.